Differential Expression of VLAβ1 (CD29) on Monocytes From Patients With Endometriosis
- 1 November 1995
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 34 (5) , 317-322
- https://doi.org/10.1111/j.1600-0897.1995.tb00958.x
Abstract
Previous studies have established that in vitro proliferation of endometrial cells is enhanced by peripheral blood monocytes (PBM) and suppressed by peritoneal macrophages (PM) from patients with endometriosis but only suppressed by PBM and PM obtained from normal subjects. The functional activity of PBM and PM is influenced by the engagement of numerous cell surface receptors with their respective physiological ligands. In this study, PBM and PM from fertile women (Group 1), women with unexplained infertility (Group 2), and women with limited (Group 3) or severe (Group 4) endometriosis were isolated in order to analyze these cells for the expression of CD54, CD58 and HLA-DR (immunoglobulin supergene antigens) CD18 and CD29 (integrins) and CD44 (an addresin). These cell surface antigens are involved in monocyte/macrophage trafficking, activation, signal transduction and/or adhesion. No differences were detected in the percentage of PBM expressing CD18, CD44, CD54, CD58, or HLA-DR among the four groups of subjects. Furthermore, the density of these antigens expressed on PBM was identical in patients and control subjects. In contrast, the percentage of PBM expressing CD29 (also known as VLA beta 1) and the density of CD29 expressed per cell were significantly reduced (P < 0.01) in patients with limited endometriosis compared to controls and patients with severe disease. Interestingly, although the percentage of CD29+ PBM from women with severe endometriosis was not statistically different from the percentage of CD29+ PBM from controls, the density of CD29 expressed per cell was significantly elevated among patients with severe disease. Analysis of PM from the four subject groups revealed no differences in CD29 expression or density. However, the percentage of PM expressing CD18 was significantly decreased in patients with limited (but not severe) endometriosis. Since both CD18 and CD29 play a role in cell trafficking and/or adhesion, alterations in their expression among patients with endometriosis suggest that these integrin beta chains may play a role in the pathogenesis of the disease.Keywords
This publication has 20 references indexed in Scilit:
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- Increased adhesion of human monocytes to IL-4-stimulated human venous endothelial cells via CD11/CD18, and very late antigen-4 (VLA-4)/vascular cell adhesion molecule-1 (VCAM-Independent mechanismsClinical and Experimental Immunology, 1993
- Mitogen Induced Production of Polyclonal IgG is Decreased in Women With Severe EndometriosisAmerican Journal of Reproductive Immunology, 1993
- Soluble CD14 participates in the response of cells to lipopolysaccharide.The Journal of Experimental Medicine, 1992
- Expression of CD54, CD58, CD14, and HLA-DR on macrophages and macrophage-derived accessory cells and their accessory capacityImmunology Letters, 1992
- Adhesion receptors of the immune systemNature, 1990
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.The Journal of Experimental Medicine, 1990
- VLA Proteins in the Integrin Family: Structures, Functions, and Their Role on LeukocytesAnnual Review of Immunology, 1990
- THE FLOW CYTOMETRIC CROSSMATCHTransplantation, 1989
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987